scholarly article | Q13442814 |
P356 | DOI | 10.1002/ANA.410200606 |
P8608 | Fatcat ID | release_5522udansfgeti3ilghpbqfd7y |
P698 | PubMed publication ID | 3813497 |
P2093 | author name string | Nelson JS | |
Fulling KH | |||
Rothman SM | |||
P2860 | cites work | Neurological manifestations in sickle-cell disease, with a review of the literature and emphasis on the prevalence of hemiplegia | Q39957290 |
Cerebrovascular disease in sickle cell anemia: a clinical, pathological and radiological correlation | Q42441425 | ||
Progressive dementia, visual deficits, amyotrophy, and microinfarcts | Q48482712 | ||
CHANGES IN BRAIN AND PIAL VESSELS IN ARTERIAL BORDER ZONES; A STUDY OF 13 CASES. | Q51273432 | ||
P433 | issue | 6 | |
P921 | main subject | sickle-cell disease | Q185034 |
P304 | page(s) | 684-690 | |
P577 | publication date | 1986-12-01 | |
P1433 | published in | Annals of Neurology | Q564414 |
P1476 | title | Sickle cell anemia and central nervous system infarction: a neuropathological study | |
P478 | volume | 20 |
Q38089946 | Advances in understanding the pathogenesis of cerebrovascular vasculopathy in sickle cell anaemia. |
Q35901965 | An unexpected full neurological recovery after cardiac arrest in a sickle cell anemia patient with bilateral cervical carotid artery disease |
Q37637900 | Arterial ischemic stroke in children: risk factors and etiologies |
Q33595279 | Atherogenesis and iron: from epidemiology to cellular level |
Q38000155 | Atherosclerosis in sickle cell disease - a review |
Q36761420 | Central nervous system complications of sickle cell disease in children: an overview |
Q42482142 | Cerebral blood flow mapping using stable xenon-enhanced CT in sickle cell cerebrovascular disease |
Q36349336 | Cerebral hemodynamic assessment and neuroimaging across the lifespan in sickle cell disease |
Q70587695 | Cerebrovascular accidents in sickle cell disease. Risk factors and blood transfusion influence. French Study Group on Sickle Cell Disease |
Q36392798 | Cerebrovascular disease associated with sickle cell pulmonary hypertension |
Q36328563 | Characterization of the hypercoagulable state in patients with sickle cell disease. |
Q37590444 | Childhood and teenage stroke |
Q36921338 | Childhood arterial ischemic stroke: a review of etiologies, antithrombotic treatments, prognostic factors, and priorities for future research |
Q45928561 | Chronic blood transfusion for primary and secondary stroke prevention in Nigerian children with sickle cell disease: a 5-year appraisal. |
Q37033939 | Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies. |
Q35552533 | Cytokines in sickle cell disease |
Q36065185 | Defining stroke risk in children with sickle cell anaemia |
Q36951397 | Ectasia of the basilar artery in children with sickle cell disease: relationship to hematocrit and psychometric measures |
Q53610886 | Elevated blood flow velocity in the anterior cerebral artery and stroke risk in sickle cell disease: extended analysis from the STOP trial. |
Q81351640 | Evidence of cranial artery ectasia in sickle cell disease patients with ectasia of the basilar artery |
Q35900346 | FGF-2 regulation of neurogenesis in adult hippocampus after brain injury |
Q36508981 | Genetic endothelial systems biology of sickle stroke risk |
Q90602349 | Genetic, laboratory and clinical risk factors in the development of overt ischemic stroke in children with sickle cell disease |
Q40890498 | Hematologic emergencies. Management of transfusion reactions and crises in sickle cell disease |
Q49191856 | Hypoxic-ischemic encephalopathy following vaso-occlusive crisis in hemoglobin SC disease |
Q42401588 | Increased stroke size following MCA occlusion in a mouse model of sickle cell disease |
Q30959505 | Intracranial magnetic resonance angiography |
Q48631780 | Kindergarten readiness skills in children with sickle cell disease: evidence of early neurocognitive damage? |
Q48325325 | Large-Vessel Vasculopathy in Children With Sickle Cell Disease: A Magnetic Resonance Imaging Study of Infarct Topography and Focal Atrophy |
Q33929537 | Lessons from the Stroke Prevention Trial in Sickle Cell Anemia (STOP) study |
Q49338284 | Lower Transcranial Doppler Flow Velocities in Sickle Cell Anemia Patients on Hydroxyurea: Myth or Fact |
Q33379114 | Morphological and functional platelet abnormalities in Berkeley sickle cell mice |
Q34117407 | Neuropsychological aspects of pediatric sickle cell disease |
Q48690055 | Nocturnal hypoxaemia and central-nervous-system events in sickle-cell disease |
Q37059565 | Nocturnal oxygen desaturation and disordered sleep as a potential factor in executive dysfunction in sickle cell anemia |
Q36657988 | Paradoxical protection from atherosclerosis and thrombosis in a mouse model of sickle cell disease. |
Q35848672 | Pathology of Berkeley sickle cell mice: similarities and differences with human sickle cell disease |
Q36483981 | Pathophysiology and treatment of stroke in sickle-cell disease: present and future |
Q57452740 | Pathophysiology of Sickle Cell Disease |
Q41257222 | Pathophysiology of vaso-occlusion |
Q36101598 | Peak Systolic Velocity Measurements with Transcranial Doppler Ultrasound Is a Predictor of Incident Stroke among the General Population in China |
Q34703702 | Pediatric stroke: the importance of cerebral arteriopathy and vascular malformations |
Q73321111 | Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia |
Q46393531 | Platelet activation in patients with sickle cell disease |
Q35535204 | Pleiotropic effects of intravascular haemolysis on vascular homeostasis |
Q34385702 | Predictors of cerebral arteriopathy in children with arterial ischemic stroke: results of the International Pediatric Stroke Study |
Q45101580 | Prevalence of intracranial stenosis and silent cerebral infarcts in children with sickle cell anemia and low risk of stroke |
Q51697475 | Primary hemorrhagic stroke in a 12-year-old female with sickle cell disease and normal transcranial Doppler. |
Q36105129 | Prospects for primary stroke prevention in children with sickle cell anaemia |
Q52726275 | Proteomic analysis of plasma from children with sickle cell anemia and silent cerebral infarction. |
Q54109052 | Prothrombotic changes in children with sickle cell disease: relationships to cerebrovascular disease and transfusion. |
Q48610574 | Radiographic predictors of neurocognitive functioning in pediatric Sickle Cell disease. |
Q47236829 | Red cell exchange transfusions lower cerebral blood flow and oxygen extraction fraction in pediatric sickle cell anemia. |
Q47414741 | Sickle Mice Are Sensitive to Hypoxia/Ischemia-Induced Stroke but Respond to Tissue-Type Plasminogen Activator Treatment |
Q34636632 | Sickle cell anaemia: progress in pathogenesis and treatment |
Q53090485 | Sickle cell disease in children: accuracy of imaging transcranial Doppler ultrasonography in detection of intracranial arterial stenosis. |
Q46518578 | Sickle cell disease with double stroke in a Moroccan family |
Q34733113 | Sickle cell disease: the neurological complications |
Q51055751 | Sickle cell disorders and chronic intravascular haemolysis are associated with low plasma heparin cofactor II. |
Q28287003 | Sickle-cell disease |
Q27026479 | Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia |
Q58725158 | Silent infarcts in sickle cell disease occur in the border zone region and are associated with low cerebral blood flow |
Q42507979 | Stenosis or hyperperfusion in sickle cell disease--ultrasound assessment of cerebral blood flow volume |
Q58320277 | Stroke and cerebrovascular disease in childhood |
Q48956949 | Stroke associated with obstructive sleep apnea in a child with sickle cell anemia |
Q34298893 | Stroke in children with sickle cell anaemia: aetiology and treatment |
Q46768117 | Stroke with intracranial stenosis is associated with increased platelet activation in sickle cell anemia |
Q41677350 | Strokes in childhood |
Q33607986 | The acute chest syndrome in sickle cell disease. Possible role of nitric oxide in its pathophysiology and treatment |
Q41356014 | The endothelial biology of sickle cell disease |
Q36811118 | Therapy insight: stroke risk and its management in patients with sickle cell disease. |
Q44040196 | Thrombin generation in children with sickle cell disease: relationship with age, hemolysis, transcranial Doppler velocity, and hydroxyurea treatment |
Q30898737 | Unruptured intracranial aneurysms in children with sickle cell disease: analysis of 18 aneurysms in 5 patients |
Q38612491 | Update on stroke risk factors. |
Q93047390 | Vascular Instability and Neurological Morbidity in Sickle Cell Disease: An Integrative Framework |
Q34992760 | Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions |
Search more.